Loading…
Korro Bio, Inc. is projected to rise to $18.62 by 2027, a +28% move from its current price of $14.56. KRRO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $13.91 | $14.56 | $15.23 | -0.02% |
| Jul 13 | $13.65 | $14.55 | $15.52 | -0.04% |
| Jul 14 | $13.45 | $14.55 | $15.74 | -0.06% |
| Jul 15 | $13.28 | $14.55 | $15.93 | -0.08% |
| Jul 16 | $13.14 | $14.55 | $16.10 | -0.09% |
| Jul 17 | $13.01 | $14.54 | $16.26 | -0.11% |
| Jul 18 | $12.89 | $14.54 | $16.40 | -0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.89 | $14.54 | $16.40 | -0.13% |
| Week 2 | $12.25 | $14.52 | $17.21 | -0.27% |
| Week 3 | $11.78 | $14.50 | $17.86 | -0.40% |
| Week 4 | $11.39 | $14.48 | $18.42 | -0.53% |
| Week 5 | $11.05 | $14.46 | $18.93 | -0.66% |
| Week 6 | $10.76 | $14.44 | $19.39 | -0.79% |
| Week 7 | $10.49 | $14.43 | $19.83 | -0.93% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Korro Bio, Inc. is a biopharmaceutical company engaged in discovering, developing, and commercializing genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The lead product candidate is KRRO-121 for the treatment for hyperammonemia.
The company uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. Korro Bio has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio was founded in 2018 and is based in Cambridge, Massachusetts.
The asset is Korro Bio, Inc. (KRRO), in the Healthcare category. It is currently priced at $14.49, with a market capitalization of $208.98M, and a rank of 3803.
A major floor 37.6% below — a decisive break under it would weaken the trend.
The nearest floor, 27.7% below — buyers have tended to step in here.
Price is pressing into resistance (1.1% away) — a breakout level to watch.
A major ceiling 19.9% above — clearing it would confirm fresh momentum.
Key KRRO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KRRO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $14.43 | Buy | $14.34 | Buy |
| MA 10 | $13.89 | Buy | $13.96 | Buy |
| MA 20 | $13.05 | Buy | $13.33 | Buy |
| MA 50 | $12.27 | Buy | $12.67 | Buy |
| MA 100 | $12.24 | Buy | $12.89 | Buy |
| MA 200 | $16.41 | Sell | $15.20 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 62.18 | Neutral |
| Stoch RSI (14) | 82.41 | Sell |
| CCI (20) | 91.87 | Neutral |
| Williams %R (14) | -6.27 | Info |
| MACD (12,26,9) | 0.17 | Buy |
| ROC (12) | 6.20 | Buy |
| Bollinger %B (20,2) | 0.79 | Neutral |
| Stochastic %K (14) | 93.73 | Sell |
| TRIX (15) | 0.65 | Buy |
| Awesome (5,34) | 1.91 | Buy |
| Ultimate (7,14,28) | 72.06 | Sell |
| Momentum (10) | 2.39 | Buy |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 14.78 | Sell |
| ADX (14) | 17.82 | Neutral |
| ATR (14) | 0.47 | Info |
The 30-day technical picture is bullish, with RSI14 at 60 and moving averages shaping the trend: SMA50 at $12.17 and SMA200 at $16.71. Support sits at $10.53 and resistance at $14.49. The 30-day price range runs from $10.48 to $20.03, reflecting notable volatility in the near term (annualized volatility 90%).
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.00 | $14.56 | $18.97 | 0% | Neutral | |
| $13.91 | $18.62 | $26.84 | +28% | Bullish | |
| $15.35 | $21.61 | $32.94 | +48% | Bullish | |
| $19.66 | $28.87 | $45.95 | +98% | Bullish | |
| $22.22 | $33.90 | $55.93 | +133% | Bullish | |
| $19.79 | $31.27 | $53.22 | +115% | Bullish | |
| $21.00 | $34.32 | $60.03 | +136% | Bullish | |
| $21.28 | $35.89 | $64.36 | +147% | Bullish | |
| $24.60 | $42.79 | $78.49 | +194% | Bullish | |
| $33.94 | $60.82 | $113.92 | +318% | Bullish | |
| $33.92 | $70.01 | $142.92 | +381% | Bullish | |
| $75.64 | $168.08 | $386.59 | +10.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $8.00 | $14.56 | $16.84 | +0.00% |
| August 2026 | $11.40 | $13.70 | $17.09 | -5.87% |
| September 2026 | $11.76 | $14.31 | $18.17 | +4.42% |
| October 2026 | $11.42 | $14.04 | $18.09 | -1.90% |
| November 2026 | $10.98 | $13.61 | $17.76 | -3.05% |
| December 2026 | $11.50 | $14.37 | $18.97 | +5.61% |
Click any year to see its month-by-month KRRO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, KRRO could reach as high as $18.97, with a base case around $14.56 and support toward $8.00 — roughly 0% from $14.56. A consolidation phase looks the most probable path here.
Expect KRRO to range from $13.91 to $26.84 through 2027. The $18.62 average target implies a +28% move from current prices. That is up +28% on the projected 2026 average. Momentum favours further upside here.
The KRRO price prediction for 2028 points to an average of $21.61 (low $15.35, high $32.94) — a potential gain of +48% on today's $14.56. Buyers look set to stay in control over this stretch.
In 2029, KRRO is projected to trade between $19.66 and $45.95, averaging $28.87 — a potential gain of +98% from today's $14.56. That is up +34% on the projected 2028 average. Momentum favours further upside here.
Korro Bio, Inc.'s 2030 outlook centres on $33.90, within a $22.22 to $55.93 range. That is up +17% on the projected 2029 average. That marks a +133% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, KRRO could reach as high as $53.22, with a base case around $31.27 and support toward $19.79 — roughly +115% from $14.56. Momentum favours further upside here.
Expect KRRO to range from $21.00 to $60.03 through 2032. The $34.32 average target implies a +136% move from current prices. That is up +10% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The KRRO price prediction for 2033 points to an average of $35.89 (low $21.28, high $64.36) — a potential gain of +147% on today's $14.56. Momentum favours further upside here.
In 2034, KRRO is projected to trade between $24.60 and $78.49, averaging $42.79 — a potential gain of +194% from today's $14.56. That is up +19% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Korro Bio, Inc.'s 2035 outlook centres on $60.82, within a $33.94 to $113.92 range. That is up +42% on the projected 2034 average. That marks a +318% change versus current levels. Momentum favours further upside here.
By 2040, KRRO could reach as high as $142.92, with a base case around $70.01 and support toward $33.92 — roughly +381% from $14.56. Buyers look set to stay in control over this stretch.
Expect KRRO to range from $75.64 to $386.59 through 2050. The $168.08 average target implies a +10.5x move from current prices. That is up +140% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in KRRO today (≈ 68.681319 KRRO) could be worth
$11,544.19
+$10,544.19 (+1054%) by 2050 · US Dollar
Based on the average projected KRRO price of $168.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KRROwould be worth at today's price.
$1,000 invested in KRRO on Jul 10, 2025 (≈ 73.583516 KRRO) would be worth
$1,071.38
+$71.38 (+7.1%) today · 1.07× · US Dollar
Based on a KRRO entry price of $13.59 vs. today's $14.56.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $14 | $1,040 | +4.0% |
| 1 month ago | $10.59 | $1,374.88 | +37.5% |
| 3 months ago | $12.68 | $1,148.26 | +14.8% |
| 6 months ago | $8.94 | $1,628.64 | +62.9% |
| 1 year ago | $13.59 | $1,071.38 | +7.1% |
| All time (5.0y) ago | $447 | $32.57 | -96.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KRRO forecast.
Our base-case forecast reaches $29.00 around 2030.
Implied market cap at $29.00: $418.25M
In the multi-year forecast, the averages rise from 2026 onward, with 2026 avg $14.49, min $8.00, max $19.06 and neutral sentiment. The outlook turns bullish in subsequent years, with 2027 avg $18.46, 2028 avg $21.51, 2029 avg $29.21, 2030 avg $34.13, 2031 avg $30.93, 2032 avg $34.08, 2033 avg $35.26, 2034 avg $42.40, 2035 avg $61.61, 2040 avg $68.76, and 2050 avg $168.16, accompanied by rising ROIs. Key milestones include 2030 ROI 135.6%, 2040 ROI 374.6%, and 2050 ROI 1060.5%.
These figures are estimates and not guarantees. The sentiment remains BULLISH across the longer horizon, with higher price levels indicated by the forward path.
Tap a question to reveal the answer.
Current price: $14.49. Market cap: $208.98M. Rank: 3803.
2030 avg $34.13; min $21.78; max $57.70; ROI 135.6%; sentiment BULLISH.
The forecast shows a neutral stance in 2026 and bullish sentiment from 2027 onward, with rising averages and ROIs through 2050 (e.g., 2030 ROI 135.6%, 2050 ROI 1060.5%). These are estimates, not guarantees.
Low $10.48; High $20.03.
2035 avg $61.61; min $32.81; max $118.99; ROI 325.2%; sentiment BULLISH.
Korro Bio, Inc. Community Discussion
0Share your Korro Bio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.